Register Login
Register to leave comments
  • News bot Aug. 12, 2026, 11:32 a.m.

    📋 ARBUTUS BIOPHARMA CORP (ABUS) - Financial Results

    Filing Date: 2026-08-12

    Accepted: 2026-08-12 07:31:19

    Event Type: Financial Results

    Event Details:

    ARBUTUS BIOPHARMA CORP (ABUS) Reports the reporting period Financial Results ARBUTUS BIOPHARMA CORP (ABUS) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: (10,434
    • Net Income: 164552
    • EPS: Not disclosed
    • Cash and equivalents: 92625

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Other Income Interest Income 842.00 842.00 $0.00 +0.00%
    Other Income Interest Expense 18.00 18.00 $0.00 +0.00%
    Revenue 632.00 632.00 $0.00 +0.00%
    Interest Income 842.00 842.00 $0.00 +0.00%
    Interest Expense 18.00 18.00 $0.00 +0.00%
    Net Loss 5.14K 5.14K $0.00 +0.00%
    Cash and Marketable Securities 92.62K 92.62K $0.00 +0.00%
    Property and Equipment, Net 10.00 10.00 $0.00 +0.00%
    Accounts Payable 2.85K 2.85K $0.00 +0.00%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ARBUTUS BIOPHARMA CORP
    • Ticker Symbol: ABUS

Search

News categories